See the source article by following the link below:
RNA-guided genome surgery using CRISPR-Cas9 used to treat age-related macular degeneration (AMD), a leading cause of blindness, in a mouse model, demonstrating that in vivo genome editing with CRISPR-Cas9 has the potential for the local treatment for nongenetic degenerative diseases.
RNA-guided genome surgery using CRISPR-Cas9 used to treat age-related macular degeneration (AMD), a leading cause of blindness, in a mouse model, demonstrating that in vivo genome editing with CRISPR-Cas9 has the potential for the local treatment for nongenetic degenerative diseases.
No comments:
Post a Comment